Michael Garwood

7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images

Signal‐to‐noise ratio (SNR), RF field (B1), and RF power requirement for human head imaging were examined at 7T and 4T magnetic field strengths. The variation in B1 magnitude was nearly twofold higher at 7T than at 4T (∼42% compared to ∼23%). The power required for a 90° pulse in the center of the head at 7T was approximately twice that at 4T. The SNR averaged over the brain was at least 1.6 times higher at 7T compared to 4T. These experimental results were consistent with calculations performed using a human head model and Maxwells equations. Magn Reson Med 46:24–30, 2001.

Simultaneous in vivo spectral editing and water suppression

Water suppression is typically performed in vivo by exciting the longitudinal magnetization in combination with dephasing, or by using frequency‐selective coherence generation. MEGA, a frequency‐selective refocusing technique, can be placed into any pulse sequence element designed to generate a Hahn spin‐echo or stimulated echo, to dephase transverse water coherences with minimal spectral distortions. Water suppression performance was verified in vivo using stimulated echo acquisition mode (STEAM) localization, which provided water suppression comparable with that achieved with four selective pulses in 3,1‐DRYSTEAM. The advantage of the proposed method was exploited for editing J‐coupled resonances. Using a double‐banded pulse that selectively inverts a J‐coupling partner and simultaneously suppresses water, efficient metabolite editing was achieved in the point resolved spectroscopy (PRESS) and STEAM sequences in which MEGA was incorporated. To illustrate the efficiency of the method, the detection of γ‐aminobutyric acid (GABA) was demonstrated, with minimal contributions from macromolecules and overlying singlet peaks at 4 T. The estimated occipital GABA concentration was consistent with previous reports, suggesting that editing for GABA is efficient when based on MEGA at high field strengths.

Symmetric pulses to induce arbitrary flip angles with compensation for rf inhomogeneity and resonance offsets

Abstract With conventional radiofrequency pulses, flip angle variation with RF field strength can limit the types of experiments that can be performed with an inhomogeneous RF coil, such as a surface coil. As an alternative, composite and adiabatic pulses can induce constant rotations even when the RF amplitude varies by >I 0-fold. Unfortunately, these pulses generally afford compensation for RF inhomogeneity at the expense of greatly increased RF power and reduced bandwidth (off resonance performance). In this paper, a procedure is described for constructing symmetric composite and adiabatic pulses which provide compensation for RF inhomogeneity while maintaining wide and symmetric bandwidths. Using this procedure, a symmetric adiabatic pulse, BIR-4, is derived which can induce a constant rotation of any desired flip angle despite RF inhomogeneity and resonance offset. In comparison to adiabatic half-passage, the 90° BIR-4 has a wider bandwidth over a similar operational range of RF amplitudes (or power). These new pulses are evaluated by numerical calculations and by surface-coil phantom experiments.

9.4T human MRI: preliminary results.

This work reports the preliminary results of the first human images at the new high‐field benchmark of 9.4T. A 65‐cm‐diameter bore magnet was used together with an asymmetric 40‐cm‐diameter head gradient and shim set. A multichannel transmission line (transverse electromagnetic (TEM)) head coil was driven by a programmable parallel transceiver to control the relative phase and magnitude of each channel independently. These new RF field control methods facilitated compensation for RF artifacts attributed to destructive interference patterns, in order to achieve homogeneous 9.4T head images or localize anatomic targets. Prior to FDA investigational device exemptions (IDEs) and internal review board (IRB)‐approved human studies, preliminary RF safety studies were performed on porcine models. These data are reported together with exit interview results from the first 44 human volunteers. Although several points for improvement are discussed, the preliminary results demonstrate the feasibility of safe and successful human imaging at 9.4T. Magn Reson Med, 2006.

In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.

This work describes a methodology for quantifying levels of total choline‐containing compounds (tCho) in the breast using in vivo 1H MR spectroscopy (MRS) at high field (4 Tesla). Water is used as an internal reference compound to account for the partial volume of adipose tissue. Peak amplitudes are estimated by fitting one peak at a time over a narrow frequency band to allow measurement of small metabolite resonances in spectra with large lipid peaks. This quantitative method significantly improves previously reported analysis methods by accounting for the variable sensitivity of breast 1H MRS measurements. Using this technique, we detected and quantified a tCho peak in 214 of 500 in vivo spectra. tCho levels were found to be significantly higher in malignancies than in benign abnormalities and normal breast tissues, which suggests that this technique could be used to diagnose suspicious lesions and monitor response to cancer treatments. Magn Reson Med 50:1134–1143, 2003.

In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent.

One of the cardinal pathologic features of Alzheimers disease (AD) is the formation of senile, or amyloid, plaques. Transgenic mice have been developed that express one or more of the genes responsible for familial AD in humans. Doubly transgenic mice develop “human‐like” plaques, providing a mechanism to study amyloid plaque biology in a controlled manner. Imaging of labeled plaques has been accomplished with other modalities, but only MRI has sufficient spatial and contrast resolution to visualize individual plaques noninvasively. Methods to optimize visualization of plaques in vivo in transgenic mice at 9.4 T using a spin echo sequence based on adiabatic pulses are described. Preliminary results indicate that a spin echo acquisition more accurately reflects plaque size, while a T2* weighted gradient echo sequence reflects plaque iron content, not plaque size. In vivo MRI–ex vivo MRI–in vitro histologic correlations are provided. Histologically verified plaques as small as 50 μm in diameter were visualized in living animals. To our knowledge this work represents the first demonstration of noninvasive in vivo visualization of individual AD plaques without the use of a contrast agent. Magn Reson Med 52:1263–1271, 2004.

Proton T2 relaxation study of water, N-acetylaspartate, and creatine in human brain using Hahn and Carr-Purcell spin echoes at 4T and 7T.

Carr‐Purcell and Hahn spin‐echo (SE) measurements were used to estimate the apparent transverse relaxation time constant (T  †2 ) of water and metabolites in human brain at 4T and 7T. A significant reduction in the T  †2 values of proton resonances (water, N‐acetylaspartate, and creatine/phosphocreatine) was observed with increasing magnetic field strength and was attributed mainly to increased dynamic dephasing due to increased local susceptibility gradients. At high field, signal loss resulting from T  †2 decay can be substantially reduced using a Carr‐Purcell‐type SE sequence. Magn Reson Med 47:629–633, 2002.

3-D FLASH imaging using a single surface coil and a new adiabatic pulse, BIR-4.

A new adiabatic pulse, which can induce uniform and arbitrary flip angles despite the presence of transmitter coil magnetic field (B1) inhomogeneities, is employed for 3-D fast imaging using a single surface coil for pulse transmission and signal detection. Computer calculations and phantom, rat, and human surface coil imaging experiments demonstrate the utility of this adiabatic pulse for T1-weighted imaging with a transmitter coil which generates a highly inhomogeneous B1 field profile.

In Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice

The ability to detect individual Alzheimers amyloid plaques in vivo by magnetic resonance microimaging (MRI) should improve diagnosis and also accelerate discovery of effective therapeutic agents for Alzheimers disease (AD). Here, we perform in vivo and ex vivo MRI on double transgenic AD mice as well as wild-type mice at varying ages and correlate these with thioflavin-S and iron staining histology. Quantitative counts of individual plaques on MRI increase with age and correlate with histologically determined plaque burden. Plaques 20 μm in diameter can be detected in AD mice as young as 3 months of age with ex vivo MRI. Plaques 35 μm in diameter can be detected by 9 months of age with in vivo MRI. In vivo MRI of individual Alzheimers amyloid plaques provides a noninvasive estimate of plaque burden in transgenic AD mice that might be useful in assessing the efficacy of amyloid reduction therapies.

Bioenergetic abnormalities associated with severe left ventricular hypertrophy.

Transmurally localized 31P-nuclear magnetic resonance spectroscopy (NMR) was used to study the effect of severe pressure overload left ventricular hypertrophy (LVH) on myocardial high energy phosphate content. Studies were performed on 8 normal dogs and 12 dogs with severe left ventricular hypertrophy produced by banding the ascending aorta at 8 wk of age. Spatially localized 31P-NMR spectroscopy provided measurements of the transmural distribution of myocardial ATP, phosphocreatine (CP), and inorganic phosphate (Pi); spectra were calibrated from measurements of ATP content in myocardial biopsies using HPLC. Blood flow was measured with microspheres. In hypertrophied hearts during basal conditions, ATP was decreased by 42%, CP by 58%, and the CP/ATP ratio by 32% in comparison with normal. Increasing myocardial blood flow with adenosine did not correct these abnormalities, indicating that they were not the result of persistent hypoperfusion. Atrial pacing at 200 and 240 beats per min caused no change in high energy phosphate content in normal hearts but resulted in further CP depletion with Pi accumulation in the inner left ventricular layers of the hypertrophied hearts. These changes were correlated with redistribution of blood flow away from the subendocardium in LVH hearts. These findings demonstrate that high energy phosphate levels and the CP/ATP ratio are significantly decreased in severe LVH. These abnormalities are proportional to the degree of hypertrophy but are not the result of persistent abnormalities of myocardial perfusion. In contrast, depletion of CP and accumulation of Pi during tachycardia in LVH are closely related to the pacing-induced perfusion abnormalities and likely reflect subendocardial ischemia.